GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.

Overview of attention for article published in Diabetes Care, November 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 67 news outlets
blogs: 5 blogs
twitter: 262 X users
patent: 1 patent
facebook: 3 Facebook pages

wikipedia: 7 Wikipedia pages
reddit: 60 Redditors
video: 3 YouTube creators
bluesky: 4 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 208 Mendeley

So far, Altmetric has seen 301 X posts from 262 X users, with an upper bound of 1,270,289 followers.

@barisgultekinnn @seblalbes https://t.co/eTGayU40Cc GLP-1 Receptor Agonists and the Risk of Thyroid Cancer - PubMed https://t.co/JM08q0BD3n

NOVEMBER 10 2022 GLP-1 Receptor Agonists and the Risk of Thyroid Cancer | Diabetes Care | #BlackBoxWarning https://t.co/OsAhr7AHr3

https://t.co/Yy2C0WYIRT

C-celtumoren komen voor in de schildklier bij blootstelling aan GLP-1-receptoragonisten. Hogere percentages schildklierkanker bij mensen die semaglutide gebruikten, vooral na 1 tot 3 jaar gebruik. GLP-1 Receptor Agonists and the Risk of Thyroid Cance…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 297 additional X posts.